| Autor: |
Nizinski, Jan, Filberek, Piotr, Sibrecht, Greta, Krauze, Tomasz, Zielinski, Jacek, Piskorski, Jaroslaw, Wykretowicz, Andrzej, Guzik, Przemyslaw |
| Předmět: |
|
| Zdroj: |
British Journal of Clinical Pharmacology; Nov2021, Vol. 87 Issue 11, p4283-4292, 10p |
| Abstrakt: |
Aims: Transient ischaemia and reperfusion (TIAR) induce early ischaemic preconditioning (IPC) in different tissues and organs, including the skin. IPC protects tissues by modifying the mitochondrial function and decreasing the amount of the reduced form of nicotinamide adenine dinucleotide (NADH). Skin 460‐nm autofluorescence is proportional to the NADH content and can be non‐invasively measured during TIAR. We propose a non‐invasive in vivo human model of skin IPC for studying the effects of repeated TIARs on the NADH content. Methods: Fifty‐one apparently healthy volunteers (36 women) underwent three 100‐second forearm ischaemia episodes induced by inflation of brachial pressure cuff to the pressure of 60 mmHg above systolic blood pressure, followed by 500‐second long reperfusion episodes. Changes in skin NADH content were measured using 460‐nm fluorescence before and during each of the three TIARs. Results: The first two TIARs caused a significant reduction in the skin NADH content before (P =.0065) and during the third ischaemia (P =.0011) and reperfusion (P =.0003) up to 3.0%. During the third TIAR, the increase in skin NADH was 20% lower than during the first ischaemia (P =.0474). Conclusions: The measurement of the 460‐nm fluorescence during repeated TIARs allows for a non‐invasive in vivo investigation of human skin IPC. Although IPC reduces the overall NADH skin content, the most noticeable NADH reduction appears during ischaemia after earlier TIARs. Studying the skin model of IPC may provide new avenues for in vivo physiological, clinical and pharmacological research on mitochondrial metabolism. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text